tbuckley/cabot-search huggingface dataset:
THE EFFECT OF DRUG-ELUTING STENTS ON CLINICAL AND ANGIOGRAPHIC OUTCOMES IN RENAL FAILURE PATIENTS WITH DIALYSIS: MULTICENTER REGISTRY IN ASIA
Authors: Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Hans Yeo, Wasan Udayachalerm, Damras Tresukosol
Journal: Journal of the American College of Cardiology (2012)
银屑病全身治疗的持久性和有效性
Authors: K.J. Mason, S. Williams, Z.Z.N. Yiu, K. McElhone, D.M. Ashcroft, C.E. Kleyn, Z.K. Jabbar‐Lopez, C.M. Owen, N.J. Reynolds, C.H. Smith, N. Wilson, R.B. Warren, C.E.M. Griffiths
Journal: British Journal of Dermatology (2019)

卫生监督机构英国国家卫生与临床优化研究所(NICE)建议中度至严重银屑病患者应该在适合生物制剂治疗之前至少尝试两种非生物全身治疗。遗憾的是,目前有很少研究对比不同药物并提供与其功效持续时间有关的信息。来自英国多个主要中心的作者利用MEDLINE、PubMed和Embase等数据库对用于治疗银屑病的主要非生物制剂进行了一次系统回顾(一种回顾科学研究的高质量方法)。他们分析了411项研究,相当于4624名患者,其中8项在研究中招募了100多名患者。因不良事件(意外的副作用)停止治疗在富马酸酯类药物(43‐46%)治疗中较甲氨喋呤(22%)更常见。在一项研究中,一年后50%仍接受甲氨喋呤治疗,42%接受依曲替酸治疗,但仅22%接受环孢素治疗。但这可能反映了一个事实,即环孢素一般用于短期治疗,因为长期使用时毒性增加。在其他研究中,停止甲氨喋呤治疗的平均时间在7.7~22.3个月之间,然而富马酸酯类药物为28~50个月。76%使用富马酸酯类药物的患者及59%甲氨喋呤治疗患者达到银屑病面积减少和严重程度指数(PASI评分)下降大于75%。PASI用于记录患者银屑病的发红程度、厚度和鳞屑,并用于衡量疗效(PASI分值降低,即表示症状减轻);例如PASI 75表示患者与最开始时的PASI分数相比降低75%或更多。作者得出结论,很难对比目前可用的研究,这是因为他们采用不同的分析方法,另外还强调了高质量长期观察性研究的需求(即,研究人员在不尝试改变谁暴露或谁不暴露的情况下观察治疗的功效)。
INCONTINENTIA PIGMENTI.
Authors: K. D. LAHIRI
Journal: British Journal of Dermatology (1955)

Journal Article INCONTINENTIA PIGMENTI. Get access K. D. LAHIRI, M.B., B.S.(India). M.D.(Zurich), Ph.D.(Edin.), D.T.M.& H.(London). K. D. LAHIRI, M.B., B.S.(India). M.D.(Zurich), Ph.D.(Edin.), D.T.M.& H.(London). Assistant Professor of Dermatology, Calcutta Medical College, University of Calcutta, Calcutta, India Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 67, Issue 8-9, 1 August 1955, Pages 310–312, https://doi.org/10.1111/j.1365-2133.1955.tb12740.x Published: 01 August 1955
Acta Cardiologica, Brussels
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TREATMENT OF UNUNITED FRACTURES OF THE NECK OF THE FEMUR BY BONE TRANSPLANTS
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Phase I/II Study of Vosaroxin and Decitabine in Newly Diagnosed Older Patients (pts) with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Authors: Naval Daver, Hagop M. Kantarjian, Guillermo Garcia-Manero, Elias Jabbour, Naveen Pemmaraju, Kenneth Vaughan, Sherry Pierce, Marina Konopleva, Tapan Kadia, Courtney DiNardo, Gautam Borthakur, Jorge E. Cortes, Adam R Craig, Farhad Ravandi
Journal: Blood (2015)
Adjuvant Regorafenib (Reg) in Stage Iv Colorectal Cancer (Crc) After Curative Treatment of Liver Metastases: a Phase III Randomized, Placebo (Pbo)-Controlled Trial (Coast)
Authors: A. Grothey, T. Yoshino, R. Xu, J. Zalcberg, D.J. Sargent, M. Choti, M. Rutstein, L. Cupit, I. Kuss, E. Van Cutsem
Journal: Annals of Oncology (2014)
LeVeen Shunt
Journal: JAMA (1977)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mitomycin C therapy in advanced gastrointestinal cancer
Authors: C. G. Moertel
Journal: JAMA (1968)

Mitomycin C (NSC-26980) is a chemotherapeutic agent capable of producing objective regressions in gastrointestinal cancer at a rate approximately comparable to that of the fluorinated pyrimidines. It can be administered intravenously, with clinically tolerable toxicity, either by prolonged, low-dosage schedule or by a short, intensive course. The latter method presents fewer practical problems. The brief duration of tumor regressions obtained, the hazard of infiltration ulcers, and the compounding of toxicity with repeated treatment are factors which seriously limit the usefulness of the agent, however, and it cannot be recommended for routine clinical use.
DR. WILSON PROTESTS PREMATURE ANNOUNCEMENT OF DEATH
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medicolegal Rounds
Authors: Don Harper Mills
Journal: JAMA (1974)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Eosinophil cationic protein's role in human hepatic allograft rejection
Authors: P Foster
Journal: Hepatology (1991)

Although it is known that eosinophils consistently infiltrate rejecting human liver allografts, their function is unknown. Infiltrating eosinophils can release a cytotoxic substance, eosinophil cationic protein. Furthermore, eosinophil cationic protein may be identified in biopsy specimens using immunoperoxidase staining of an eosinophil cationic protein-specific monoclonal antibody. To study a possible effector role of eosinophils in rejecting liver allografts, 38 serial allograft biopsy specimens from 12 patients with acute rejection, 54 biopsy specimens from 11 patients with allograft dysfunction caused by other causes and 22 biopsy specimens from 8 patients without allograft dysfunction were stained for extracellular eosinophil cationic protein. In addition, the absolute blood eosinophil counts and the portal tract eosinophil percent of the total number of portal tract inflammatory cells were tabulated in these patients until 30 days after transplantation. The blood absolute eosinophil count, portal tract eosinophil percent and incidence of positive extracellular eosinophil cationic protein staining were significantly increased in patients with rejection compared with patients with dysfunction from other causes (p < 0.05 to 0.005, t test). Furthermore, each of these parameters predicted rejection with excellent sensitivity (75% to 92%) and specificity (91% to 100%). Of patients with rejection, 59% had significant elevation of all three parameters before or during rejection, and 92% had at least two parameters elevated. Conversely, of the patients with dysfunction from other causes, 0% had elevations of any parameter. The recognized cytotoxic properties of eosinophil cationic protein and its almost exclusive presence, along with eosinophils in the blood and allograft biopsy specimens of patients during acute rejection, support the role of the eosinophil as an effector cell in tissue injury during acute liver allograft rejection. (HEPATOLOGY 1991;13:1117–1125.)
Granulocytopoiesis
Authors: E. P. Cronkite, T. M. Fliedner
Journal: New England Journal of Medicine (1964)

IN consideration of the total picture of granulocytopoiesis one must consider each phase of a cell proliferation system that is in a steady-state equilibrium§ with fluxes superimposed upon the steady-state equilibrium by physiologic influxes into the blood and effluxes from the blood. The net result under conditions of health is a steady-state equilibrium. Although many schemes for granulocytopoiesis, showing the relation of the stem cell to proliferation and differentiation, have been drawn in the textbooks of hematology in the past it is necessary to consider the structure of each cytologic compartment as reported by Killmann et al.1 in which a . . .
RHEUMATOID ARTHRITIS
Authors: P. Newell
Journal: BMJ (1913)

JOURNAL of April 26th, he says if Dr. Luff has any doubt about the extraction of the lime salts from the bones he had better look at some skiagrams.I think Dr. Luff's doubts upon this point are well founded, and I suggest that something further than the evidence from skiagrams is needed to prove this point.During recent years I have taken a large number of skiagrams at the Royal Mineral Water Hospital, and the 'conclusion I have come to is that in rheumatoid arthritis, and in other diseases where the tissues are wasted, the bones are more translucent than is normal, but that no reliance in diagnosis could be based upon this method.According to Sir James Barr, rheumatoid arthritis begins in the larger joints and spreads to the smaller.This is entirely contrary to my experience.It is in the smaller joints, especially of the hand, that it first begins, and often, as Dr. Kient Spender pointed out, in the joint and muscles of the thumb.That it is more common among the poorer classes I quite allow, but it is also seen only too often among the well to do.If the poverty of the one causes the "*mild chronic acidosis," does the plenty of the other do the same?
Molecular Action of the l(2)gl Tumor Suppressor Gene of Drosophila melanogaster
Authors: Reinhard Merz, Martina Schmidt, Istvan Torok, Ursula Protin, Gerd Schuler, Hans-Peter Walther, Frank Krieg, Monika Gross, Dennis Strand, Bernard M. Mechler
Journal: Environmental Health Perspectives (1990)

Tumor suppressor genes act as recessive determinants of cancer. These genes contribute to the normal phenotype and are required for regulating cell growth and differentiation during development. Inactivation of tumor suppressor genes leads to an unrestricted pattern of growth in specific cell types. In Drosophila, a series of genes have been identified that cause tissue-specific tumors after mutation. Of these, the lethal(2)giant larvae (l(2)gl) gene is the best studied. Homozygous l(2)gl mutations cause the development of malignant tumors in the brain and the imaginal discs. Genomic DNA from the l(2)gl locus has been cloned, introduced back into the genome of l(2)gl-deficient animals, and shown to reinstate normal development. The nucleotide sequence of the l(2)gl gene has been determined, as well as the sequences of two classes of transcripts. Analysis of the spatial distribution of both l(2)gl transcripts and proteins revealed that during early embryogenesis the l(2)gl gene is uniformly expressed in all cells and tissues. In late embryos, the l(2)gl expression becomes gradually restricted to tissues presenting no morphological or neoplastic alteration in the mutant animals. Further mosaic experiments revealed that l(2)gl gene loss can cause three distinct phenotypes: neoplastic transformation, abnormal differentiation, and normal development. These phenotypes depend upon the extent of gene activity in the stem cells prior to the formation of l(2)gl- clones. These analyses indicate that the critical period for the establishment of tumorigenesis occurs during early embryogenesis at a time when the l(2)gl expression is most intense in all cells.
Epidemiological Essays.
Journal: JAMA (1931)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Beiträge zur Photographie der Blutspektra, unter Berücksichtigung der Toxikologie der Ameisensäure.
Journal: JAMA (1910)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Course of Lectures on Urine, Urinary Deposits, and Calculi
Authors: L. Beale
Journal: BMJ (1860)

UIRINARY DEPOSITS. Collecting Urine for Microscopical Exanmination.Period when the Urine should be examined.Remnoval of the Deposit from the Vessel containing it.Of Collecting a ver;y snmall qutantity of a Deposit from a Fluid.Magnifying Powers required in the Examination of Urine.Of the Chenmical Examination of Urinary Deposits.Examination of the Deposit in the Microscope.Of Placing the Deposit in tile Preservative Fluid.Refractive Powver of the Medium in which Deposits are mounted.Media in whilich Uriniary Deposits may be preserved.Of Keeping the Deposit for subsequent Inquiries.Of Pre- serrving Deposits permanently.Mlucus,
Lord Porritt
Authors: Peter Sperryn
Journal: British Journal of Sports Medicine (1994)

<b>Aim:</b> To evaluate a modified urine collection pad (UCP) method for its ability to reduce heavy mixed growth bacterial contamination of UCP samples in young children with suspected urinary tract infection (UTI). <b>Method:</b> Febrile children under 2 years of age were randomised to two UCP methods: the same UCP kept in the nappy until urine was passed (single UCP group), or the UCP replaced with a fresh one every 30 minutes until urine was passed (replaced UCP group). In both groups a moisture sensitive audio alarm was used to signal passage of urine. <b>Results:</b> Eighty children were enrolled and a satisfactory sample was obtained in 68 (37 in the single UCP group and 31 in the replaced UCP group). In 12 children (15%), collection failed, mainly because of faecal soiling of the pad. UTI occurred in three children (4%). In the remaining 65 samples, heavy mixed growth (&gt;&nbsp;10<sup>5</sup> organisms/ml) occurred in 1/31 (3%) in the replaced UCP group compared with 10/35 (29%) in the single UCP group (p&nbsp; = &nbsp;0.008). There were no adverse effects from the use of the moisture sensitive audio alarm. <b>Conclusion:</b> Changing the UCP every 30 minutes almost eliminates heavy mixed growth contamination of UCP samples and substantially increases the proportion of UCP results that confidently exclude UTI. This represents a simple and clinically important improvement to the UCP method which is reliable for diagnosing and excluding UTI in young children still in nappies. It has potential for use in outpatient clinics, in the primary healthcare setting, or at home.
Acute Myocardial Infarction
Authors: James C. Broadbent
Journal: JAMA (1969)

It is difficult to keep pace with medical progress in general and often impossible to know whether a specific new drug or procedure is of significant value. These observations are especially true for that revolutionary new concept of medical management, the coronary-care unit. Accordingly, this symposium has special interest because it details the procedures, problems, and progress in this field from the USSR to Australia. In eight sections, comprising 40 short chapters, 62 participants from 19 nations review the state of the art. Various sections deal with the dysrhythmias, heart block and pacing, heart failure, cardiogenic shock, and metabolic consequences of acute myocardial infarction. Other sections provide helpful comment on organization and administration of the coronarycare unit and its relationship to the community. Individual presentations are concise, well illustrated, and authoritative. Topics include the use of lidocaine in the treatment of arrhythmias, overdriving of dysrhythmias after acute myocardial infarction, cardiac
ATROPIN POISONING: REPORT OF A CASE
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal